Journals
Books
Articles by keyword B7-H3
Key immune checkpoints and their inhibitors in the therapy of bone tumors. Part 2. Additional targets for immunotherapy of bone tumors and markers of its efficiency

A.A. Alferov¹, M.M. Efimova², Yu.B. Kuzmin³, I.N. Kuznetsov4, E.S. Gershtein5, N.E. Kushlinskii6

1–3, 5, 6 N.N. Blokhin National Medical Research Center of Oncology of Ministry of Health of the Russian Federation (Moscow, Russia)

4 A.I. Evdokimov Moscow University of Medicine and Dentistry of Ministry of Health           of the Russian Federation (Moscow, Russia)

Ovarian cancer and B7-H3 and B7-H4 ligands

O.V. Kovaleva1, D.N. Kushlinskiy2, A.N. Gratchev3, E.P. Shapiro4, A.S. Mochalova5, N.Yu. Sokolov6, N.E. Kushlinskii7

1,3,5–7 N.N. Blokhin National Medical Research Center for Oncology
of the Ministry of Health of the Russian Federation (Moscow, Russia)

2,4 Clinical Center of Oncology (Khabarovsk, Russia)

Immune checkpoints and their soluble forms in bone tumors

N.E. Kushlinskii1, A.A. Alferov2, Yu.B. Kuzmin3, P.L. Prishchep4, I.S. Chernomaz5, N.Yu. Sokolov6, I.N. Kuznetsov7, I.S. Stilidi8

1,2,4-6,8 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

3,7 Russian University of Medicine of the Ministry of Health of Russia (Moscow, Russia)

1 kne3108@gmail.com, 2 aleksandr.alferov@yahoo.com, 3 yriikuzmin@yandex.com, 4 Paulig92@mail.ru, 5 marvel2602@mail.ru, 6 strivp@mail.ru, 7 npkredo@yandex.ru, 8 ronc@list.ru